Sun Pharmaceutical Industries has agreed to acquire Organon, a U.S.-listed global healthcare company, in a deal valued at $11.75 billion. Organon was spun off from Merck in 2021 and operates across women's health, biosimilars, and established branded medicines. The acquisition would mark Sun Pharma's largest-ever deal and significantly expand its global footprint beyond its current generics-heavy business. Organon brings a diversified portfolio with meaningful revenue from international markets, which would give Sun Pharma instant scale in segments it has been building toward organically. The deal structure and financing terms have not been detailed in available disclosures, so the capital and debt impact on Sun Pharma's balance sheet is not yet clear. For the Indian pharma sector, this is a signal that large domestic players are willing to pursue transformative acquisitions at the global level. Watch for details on deal financing, regulatory approvals across multiple markets, and how Sun Pharma plans to integrate Organon's broader product lines into its existing commercial operations.
Flipkart will launch a food delivery pilot in Bengaluru by mid-August, charging restaurants a 10-11% commission compared to the 25-35% levied by Swiggy and Zomato. The move targets growing restaurant discontent with incumbent platforms and aims to drive daily engagement across Flipkart's 500 million registered users.
Maruti Suzuki crossed two lakh domestic units in July 2026 for the first time, recording 42.4% year-on-year growth. Total sales including exports and OEM supplies reached 2,41,421 units, with all passenger vehicle segments posting gains.
Air India's net loss more than doubled to ₹22,238 crore in FY26, prompting Tata Sons chairman N Chandrasekaran to extend the Vihaan.AI turnaround timeline from five years to as long as a decade.
UpGrad's all-stock acquisition of Unacademy, valued at Rs 1,955 crore, is set to close within three weeks after CCI clearance and near-complete investor sign-offs. The deal combines upGrad's upskilling business with Unacademy's test prep and medical education platforms, with Gaurav Munjal staying on as CEO.
